Hancock Jaffe Laboratories- Warrants (30/05/2023) Total Liabilities

As of the most recent data (June 2026), HJLIW shows a total liabilities of $2M. That compares with $3.5M in the prior-year period — down 43.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HJLIW's total liabilities is now $2M (was $3.5M) — a 43.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Hancock Jaffe Laboratories- Warrants (30/05/2023) is outperforming or lagging.

Tracking HJLIW's total liabilities over time shows whether Hancock Jaffe Laboratories- Warrants (30/05/2023) is scaling, shrinking, or reshaping that part of the business. The current reading is $2M That compares with $3.5M in the prior-year period — down 43.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Hancock Jaffe Laboratories- Warrants (30/05/2023)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $2M) with ownership activity and broader fundamentals.

Hancock Jaffe Laboratories- Warrants (30/05/2023)'s total liabilities is $2M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.